NCT00905034
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,057 public trials
2,038 recruiting studies
Lymphoproliferative Disorders trial results
NCT00689507
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- UCLA Los Angeles, California, United States
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT01056510
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- Pori, Finland
- Vantaa, Finland
- Argenteuil, France
- Avignon, France
NCT01217749
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +17 more
- Locations
-
- The Ohio State University Columbus, Ohio, United States
NCT00083382
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States
NCT00990587
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +39 more
- Locations
-
- Vancouver General Hospital Vancouver, British Columbia, Canada
- Princess Margaret Hospital Toronto, Ontario, Canada
NCT01531998
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT00947739
- Conditions
- Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
- Locations
-
- University of New Mexico Cancer Center Albuquerque, New Mexico, United States
- University of Texas Health Sciences Center San Antonio, Texas, United States
NCT00563290
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +21 more
- Locations
-
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
- Ohio State University Medical Center Columbus, Ohio, United States
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701)
NCT00034684
- Conditions
- Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +22 more
- Locations
-
Not specified